We found that suppression in cell proliferation, migration and invasion induced by TXNRD1 knockdown could be rescued by SC79 treatment, while MK2206 treatment abolished the growth and motility advantages of TXNRD1 overexpression in HCC cells (Fig. 4D, E, Fig. S4A–D). This evidence concerns the gene TXNRD1 and hepatocellular carcinoma.